China offers alternative gateway for experimental drugs

Several experimental biologic drugs pioneered by Western biotechnology companies that failed to reach the US or European markets have recently been approved in China. Some argue that China could prove a useful testing ground from which to launch experimental therapies into the West. However, critics have hinted that the regulatory system in China is much more lax.